Budesonide Prophylaxis Reduces the Risk of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation in Multiple Myeloma-Reference-Cited by-同舟云学术

Budesonide Prophylaxis Reduces the Risk of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation in Multiple Myeloma

Published:2021-10 Issue:10 Volume:21 Page:e775-e781
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Dhakal Binod,Thapa Bicky,Dong Huaying,Tarima Sergey,Chhabra Saurabh,D'Souza Anita,Drobyski William,Abid Muhammad,Shah Nirav,Fenske Timothy,Longo Walter,Hari Parameswaran,Hamadani Mehdi

Funder

Medical College of Wisconsin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference24 articles.

1. Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma;Attal;N Engl J Med,2017

2. Autologous transplantation for newly diagnosed multiple myeloma in the era of novel agent induction: a systematic review and meta-analysis;Dhakal;JAMA Oncol,2018

3. Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma;Perrot;Blood,2018

4. Engraftment syndrome, the Emperor's new clothes and the artist formerly known as Prince;Gale;Bone Marrow Transplant,2015

5. Engraftment syndrome following hematopoietic stem cell transplantation;Spitzer;Bone Marrow Transplant,2001

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ciprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: A randomized trial;International Journal of Infectious Diseases;2024-10

2. Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide;Blood Reviews;2024-07